Osamu Tagao

Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy

Kwok-Kin Wong, Sreenath V. Sharma, J. Settleman, 2010, Disease Models & Mechanisms.